China SXT Pharmaceuticals (SXTC) Assets Average (2019 - 2025)
Historic Assets Average for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Q3 2025 value amounting to $24.0 million.
- China SXT Pharmaceuticals' Assets Average fell 1128.44% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 1128.44%. This contributed to the annual value of $22.4 million for FY2025, which is 1497.79% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Assets Average of $24.0 million as of Q3 2025, which was down 1128.44% from $26.3 million recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Assets Average high stood at $29.3 million for Q1 2021, and its period low was $18.9 million during Q1 2024.
- In the last 5 years, China SXT Pharmaceuticals' Assets Average had a median value of $26.7 million in 2024 and averaged $25.8 million.
- In the last 5 years, China SXT Pharmaceuticals' Assets Average plummeted by 2710.02% in 2024 and then surged by 3962.83% in 2025.
- China SXT Pharmaceuticals' Assets Average (Quarter) stood at $28.6 million in 2021, then decreased by 2.6% to $27.9 million in 2022, then decreased by 20.79% to $22.1 million in 2023, then rose by 22.61% to $27.1 million in 2024, then dropped by 11.28% to $24.0 million in 2025.
- Its last three reported values are $24.0 million in Q3 2025, $26.3 million for Q1 2025, and $27.1 million during Q3 2024.